Efficacy and safety of gemcitabine-oxaliplatin combined with huachansu in patients with advanced gallbladder carcinoma.
about
Synergistic Effect and Molecular Mechanisms of Traditional Chinese Medicine on Regulating Tumor Microenvironment and Cancer CellsBufalin, a component in Chansu, inhibits proliferation and invasion of hepatocellular carcinoma cells.Comparison of toad skins Bufo bufo gargarizans Cantor from different regions for their active constituents content and cytotoxic activity on lung carcinoma cell lines.The quality of reports of randomized clinical trials on traditional Chinese medicine treatments: a systematic review of articles indexed in the China National Knowledge Infrastructure database from 2005 to 2012Huachansu injection inhibits metastasis of pancreatic cancer in mice model of human tumor xenograft.Bufothionine induced the mitochondria-mediated apoptosis in H22 liver tumor and acute liver injury.Antiproliferative effects of cinobufacini on human hepatocellular carcinoma HepG2 cells detected by atomic force microscopy.Resibufogenin Induces G1-Phase Arrest through the Proteasomal Degradation of Cyclin D1 in Human Malignant Tumor CellsChansu inhibits the expression of cortactin in colon cancer cell lines in vitro and in vivo.Traditional Chinese medicine in the prevention and treatment of cancer and cancer metastasis.Proteasome Inhibition Contributed to the Cytotoxicity of Arenobufagin after Its Binding with Na, K-ATPase in Human Cervical Carcinoma HeLa Cells.Evaluation of Bufadienolides as the Main Antitumor Components in Cinobufacin Injection for Liver and Gastric Cancer Therapy.Gamabufotalin, a major derivative of bufadienolide, inhibits VEGF-induced angiogenesis by suppressing VEGFR-2 signaling pathway.The mechanisms of chansu in inducing efficient apoptosis in colon cancer cells.Therapeutic applications of herbal medicines for cancer patientsFunctional characterization and anti-cancer action of the clinical phase II cardiac Na+/K+ ATPase inhibitor istaroxime: in vitro and in vivo properties and cross talk with the membrane androgen receptor.Cinobufagin inhibits tumor growth by inducing intrinsic apoptosis through AKT signaling pathway in human nonsmall cell lung cancer cells.Gemox: a widely useful therapy against solid tumors-review and personal experience.Targeting Na⁺/K⁺ -translocating adenosine triphosphatase in cancer treatment.Bufalin Inhibits NCI-H460 Human Lung Cancer Cell Metastasis In Vitro by Inhibiting MAPKs, MMPs, and NF-κB Pathways.Alkaloids from the Traditional Chinese Medicine ChanSu: synthesis-enabled structural reassignment of bufopyramide to bufoserotonin C.Inhibitory efficacy of bufadienolides on Na+,K+-pump activity versus cell proliferation.Bufalin Inhibits HCT116 Colon Cancer Cells and Its Orthotopic Xenograft Tumor in Mice Model through Genes Related to Apoptotic and PTEN/AKT Pathways.Simultaneous determination of eight bufadienolides in cinobufacini injection by HPLC coupled with triple quadrupole mass spectrometry.Combination of Cinobufacini and Doxorubicin Increases Apoptosis of Hepatocellular Carcinoma Cells through the Fas- and Mitochondria-Mediated Pathways.Bufalin Suppresses Migration and Invasion of Hepatocellular Carcinoma Cells Elicited by Poly (I:C) Therapy.Cytocidal effects of arenobufagin and hellebrigenin, two active bufadienolide compounds, against human glioblastoma cell line U-87
P2860
Q26752653-7716C1A9-CC2E-4716-832D-95B2FC60200AQ31123429-B1E035DD-5535-4478-BE2D-12C60B725A12Q34158804-CD4B3468-C2A5-4C72-A9E4-205BB75A62C9Q34318550-D64E8519-814B-4C33-97C8-4551ADDECFE8Q35059946-71068974-DF5D-4390-BC26-0FC7046F527EQ35211623-7C5D554D-7F39-458C-9828-7C8DD943B3D1Q35549749-92D4E987-B1C2-4A33-B34C-8369A36D729DQ35677008-9F3A9F95-1247-441A-AB9D-2B474F4C2C9CQ35680721-21258A6B-8505-44A1-8E58-403252C6A323Q35942893-433892F8-B7E3-4018-82C3-140B1EE2F027Q36080090-F710417F-7E14-4B7C-952B-426E1A285DDCQ36247497-C2EDD6C6-C9CD-4756-A2BA-315E8FF65D9CQ36772187-24A0B195-2907-43FA-91AF-EBBDFBF1BC39Q36931329-16EE0235-1EF8-46FD-913B-8F61F202FCCAQ37055147-FD9FC7A4-02FB-4068-B3F0-56A306408A51Q37269322-19A5888F-5823-4988-ADCA-BA14E8A8CB54Q37301710-09EC38F2-C697-499A-88C1-CD48BE7D1D6DQ37814700-718E0449-088A-4CF0-B3DB-7FB971AB9392Q38367657-9CA31B46-EC97-4505-AD88-64D963A8D647Q38829650-98667FF2-AB88-4A53-936C-1724308A3D18Q40802295-62334E2C-33E3-42E7-ADC8-6B2151F22FFCQ41683113-CD4EAD20-B4D4-45A6-8E89-1D7EFD340306Q41989141-861E7B2A-DC0E-4FBC-A120-4141CACCB917Q47185485-3FEAE8C0-5F2E-490E-91D2-1A12FA449A90Q47745678-860B6FAD-1D2A-4AC6-B397-130015A6288CQ54112790-E74AE444-56BD-4E73-A4D0-1507ECF9D868Q57071952-7F52DBEC-D252-4C0B-B371-E6A9F3934B71
P2860
Efficacy and safety of gemcitabine-oxaliplatin combined with huachansu in patients with advanced gallbladder carcinoma.
description
2008 nî lūn-bûn
@nan
2008 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Efficacy and safety of gemcita ...... dvanced gallbladder carcinoma.
@ast
Efficacy and safety of gemcita ...... dvanced gallbladder carcinoma.
@en
type
label
Efficacy and safety of gemcita ...... dvanced gallbladder carcinoma.
@ast
Efficacy and safety of gemcita ...... dvanced gallbladder carcinoma.
@en
prefLabel
Efficacy and safety of gemcita ...... dvanced gallbladder carcinoma.
@ast
Efficacy and safety of gemcita ...... dvanced gallbladder carcinoma.
@en
P2093
P2860
P356
P1476
Efficacy and safety of gemcita ...... dvanced gallbladder carcinoma.
@en
P2093
Bo-Rong Pan
Ling-Xiao Zhang
Tian-Jie Qin
Xin-Han Zhao
Zhi-Ping Ruan
P2860
P304
P356
10.3748/WJG.14.5210
P407
P577
2008-09-01T00:00:00Z